TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Strängnäsvaccin AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,797
|
2,321
|
2,355 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
90
|
-146
|
-256 |
| EBITDA |
101
|
-54
|
-154 |
| Total assets |
742
|
824
|
1,121 |
| Current assets |
663
|
723
|
918 |
| Current liabilities |
67
|
64
|
94 |
| Equity capital |
668
|
757
|
1,023 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
3
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
90.0%
|
91.9%
|
91.3% |
| Turnover per employee | 932 | ||
| Profit as a percentage of turnover |
3.2%
|
-6.3%
|
-10.9% |
| Return on assets (ROA) |
12.1%
|
-17.7%
|
-22.7% |
| Current ratio |
989.6%
|
1129.7%
|
976.6% |
| Return on equity (ROE) |
13.5%
|
-19.3%
|
-25.0% |
| Change turnover |
552
|
-46
|
-179 |
| Change turnover % |
25%
|
-2%
|
-7% |
| Chg. No. of employees |
3
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.